Cancer Biomarkers

The compounds known as cancer biomarkers act as indicators of the presence of cancer in the body. The biomarker, which is often an atom released by the tumour or as a result of the tumor's proximity, is a processable sign of the body's natural state. The biomarkers are used to assess the risk for disease patients. The quantitative way to find the tumour cells is consistently provided by the cancer biomarkers, particularly those specifically associated to hereditary modifications or epigenetic modification. The most valuable feature of a biomarker is its ability to be used as a symptomatic tool to determine if a tumour is localised or has spread to other organs. The biomarkers can also influence the prognosis for cancer.

    Related Conference of Cancer Biomarkers

    December 04-05, 2023

    3rd World Summit on Transcriptomics

    Venice, Italy
    December 04-05, 2023

    17th Global meet on Rheology & Rheometry

    Taipei, Taiwan
    December 04-05, 2023

    46th International Summit on Human Anatomy & Physiology

    Taipei, Taiwan
    December 05-06, 2023

    2nd World Conference on Pharma Industry and Medical Devices

    Zurich, Switzerland
    December 07-08, 2023

    6th Annual Congress on Emergency Medicine and Acute Care

    Prague, Czech Republic
    December 18-19, 2023

    3rd World Congress on Pain Medicine and Management

    London, UK
    March 18-19, 2024

    20th International Conference on Cancer Research

    Zurich, Switzerland
    April 24-25, 2024

    33rd Neonatology and Primary Care Congress

    Paris, France
    July 25-26, 2024

    20th World Summit on Blockchain Technology

    Amsterdam, Netherlands

    Cancer Biomarkers Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in